You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華蘭疫苗(301207.SZ)IPO擬發行4001萬股 1月28日定價、2月8日申購
格隆匯 01-24 08:40

格隆匯1月24日丨華蘭疫苗(301207.SZ)披露招股意向書,此次擬公開發行股票4001萬股,佔發行後公司總股本的10.00%,發行後公司總股本為4.0001億股;全部為公開發行新股,不設老股轉讓。

此次發行初始戰略配售發行數量為600.15萬股,佔發行數量的15.00%。回撥機制啟動前,網下初始發行數量為2720.70萬股,佔扣除初始戰略配售後此次發行總量的80.00%;網上初始發行數量為680.15萬股,佔扣除初始戰略配售後此次發行總量的20.00%。

此次發行初步詢價時間為2022年1月26日,2022年1月28日確定發行價格,網上網下申購日期為2022年2月8日。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account